OMX Nordic 40
2.239,89
PKT
+20,84
PKT
+0,94
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
05.06.23 | AstraZeneca Overweight | Barclays Capital | |
05.06.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
05.06.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
02.06.23 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
02.06.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
01.06.23 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
26.05.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
26.05.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
26.05.23 | Novo Nordisk Sell | UBS AG | |
25.05.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
24.05.23 | Nokia Outperform | Credit Suisse Group | |
23.05.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
23.05.23 | Novo Nordisk Overweight | Barclays Capital | |
23.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
23.05.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
22.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
22.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
22.05.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
18.05.23 | AstraZeneca Neutral | UBS AG | |
17.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
16.05.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
16.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
16.05.23 | Nokia Overweight | JP Morgan Chase & Co. | |
11.05.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
11.05.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
11.05.23 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
09.05.23 | AstraZeneca Buy | Deutsche Bank AG | |
09.05.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
09.05.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.05.23 | A.P. Moeller - Maersk A-S (B) Neutral | UBS AG | |
05.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
05.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.05.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
05.05.23 | Novo Nordisk Outperform | Credit Suisse Group | |
04.05.23 | Novo Nordisk Sell | UBS AG | |
04.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.05.23 | AstraZeneca Buy | Deutsche Bank AG | |
03.05.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
03.05.23 | Volvo (B) Hold | Jefferies & Company Inc. | |
02.05.23 | Volvo (B) Buy | Goldman Sachs Group Inc. |